Taking tiny doses of GLP-1 medication has been touted for weight management, perimenopause symptoms, even longevity. But is ...
For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...
Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.
Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for ...
Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results